000 01645 a2200481 4500
005 20250517110550.0
264 0 _c20170830
008 201708s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2016.219
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatel, B
245 0 0 _aPegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
_h[electronic resource]
260 _bLeukemia
_c01 2017
300 _a58-64 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAsparaginase
_xadministration & dosage
650 0 4 _aChemical and Drug Induced Liver Injury
_xmortality
650 0 4 _aHumans
650 0 4 _aInduction Chemotherapy
_xmethods
650 0 4 _aMiddle Aged
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aPolyethylene Glycols
_xadministration & dosage
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xcomplications
650 0 4 _aSepsis
_xchemically induced
700 1 _aKirkwood, A A
700 1 _aDey, A
700 1 _aMarks, D I
700 1 _aMcMillan, A K
700 1 _aMenne, T F
700 1 _aMicklewright, L
700 1 _aPatrick, P
700 1 _aPurnell, S
700 1 _aRowntree, C J
700 1 _aSmith, P
700 1 _aFielding, A K
773 0 _tLeukemia
_gvol. 31
_gno. 1
_gp. 58-64
856 4 0 _uhttps://doi.org/10.1038/leu.2016.219
_zAvailable from publisher's website
999 _c26286803
_d26286803